Rate My Professor Kok Lun

Dr. Pang Kok Lun is a lecturer in the Jeffrey Cheah School of Medicine and Health Sciences at Monash University Malaysia. With nearly six years of tertiary teaching experience in medical and health science programs, he demonstrates dedication to innovative pedagogies, holding a Senior Fellowship of the UK Higher Education Academy (SFHEA) awarded in 2024 and a Postgraduate Certificate in Medical Education from Newcastle University upon Tyne, UK (2022). His academic qualifications include a PhD in Biomedical Sciences from Universiti Kebangsaan Malaysia (UKM, awarded 2018; thesis: Molecular mechanism of Goniothalamin and Trifluoromethoxy-Goniothalamin-induced apoptosis in chronic myeloid leukemia K562 cells) and a Bachelor of Biomedical Science with Honours (Distinction) from UKM (2011; thesis: Modulation of fau gene expression on catechol-induced apoptosis in WEHI-7.2 murine thymoma cells). Previously, he served as a postdoctoral researcher in the Department of Pharmacology at Hospital Universiti Kebangsaan Malaysia (2020-2021) and as an external examiner for SEGi College Kuala Lumpur (2021-2026).

Dr. Pang specializes in cancer cell biology, cell death mechanisms including apoptosis, toxicology, pharmacognosy, and extracellular vesicles, with over a decade of in-vitro research experience contributing to SDG 3: Good Health and Well-being. He has authored more than 30 publications, including four book chapters, amassing over 1,156 citations. Select key works encompass 'Extracellular Vesicles as Emerging Drug Delivery Platforms in Triple-Negative Breast Cancer: A Systematic Review' (International Journal of Nanomedicine, 2026), 'Comparative Bone-Protective Effects of Tocotrienol Isomers from Palm and Annatto in Dexamethasone-Induced Osteoporotic Male Rats' (International Journal of Molecular Sciences, 2025), 'Palm Tocotrienol Activates the Wnt3a/β-Catenin Signaling Pathway, Protecting MC3T3-E1 Osteoblasts from Cellular Damage Caused by Dexamethasone and Promoting Bone Formation' (2025), 'Effects of resveratrol on biochemical and structural outcomes in osteoarthritis: A systematic review and meta-analysis of preclinical studies' (2024), and 'Therapeutic Effects of Olive and Its Derivatives on Osteoarthritis: From Bench to Bedside' (2017). Awards include Best Oral Presenter at the Molecular Diagnostics & Biomarker Discovery Conference (2024) and Best Oral Presentation Award (2025). He holds roles as Guest Editor for Frontiers in Pharmacology (2025), Associate Editor for Frontiers in Nutrition (2025), and Executive Member of the Malaysia Society of Extracellular Vesicles (MySEV, 2025).